<DOC>
	<DOCNO>NCT00836537</DOCNO>
	<brief_summary>This study compare relative bioavailability ( rate extent absorption ) 40 mg Benazepril Hydrochloride Tablets TEVA Pharmaceuticals Industries , Ltd. 40 mg LOTENSIN® Tablets Novartis Pharmaceuticals follow single oral dose ( 1 x 40 mg ) healthy adult volunteer non-fasting condition .</brief_summary>
	<brief_title>Benazepril HCl 40 mg Tablets , Fed</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Benazepril</mesh_term>
	<criteria>Screening Demographics : All volunteer select study healthy men woman 19 year age old time dose . The weight range exceed ±20 % height body frame per Desirable Weights Men 1983 Metropolitan height Weight Table per Desirable Weights Women 1983 Metropolitan Height Weight Table . Subjects must minimum weight least 110 pound . Screening procedure : Each volunteer complete screening process within 28 day prior Period I dose . Consent document screen evaluation HIV antibody determination review , discuss , sign potential participant full implementation screening procedure . Screening include general observation , physical examination , demographic , medical medication history , 12lead electrocardiogram , sit blood pressure heart rate , respiratory rate temperature . The physical examination include , may limited evaluation cardiovascular , gastrointestinal , respiratory central nervous system . The screen clinical laboratory procedure include : 1 . Hematology : hematocrit , hemoglobin , WBC count differential , RBC count , platelet count ; 2 . Clinical Chemistry : serum creatinine , BUN , glucose , AST ( GOT ) , ALT ( GPT ) , albumin , total bilirubin , total protein , alkaline phosphatase ; 3 . HIV antibody , hepatitis B surface antigen , hepatitis C antibody screen ; 4 . Urinalysis : dipstick ; full microscopic examination dipstick positive ; 5 . Urine Drug Screen : ethyl alcohol , amphetamine , barbiturate , benzodiazepine , cannabinoids , cocaine metabolite , opiates phencyclidine . 6 . Serum Pregnancy Screen ( female volunteer ) If female : 1. childbearing potential , practice acceptable method birth control duration study judge investigator ( ) , condom , sponge , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . 2. postmenopausal least 1 year ; 3. surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy Volunteers recent history drug alcohol addiction abuse past 24 month . Volunteers presence clinically significant disorder involve cardiovascular , respiratory , renal , gastrointestinal , immunologic , hematologic , endocrine , neurologic system ( ) psychiatric disease ( determine bt medical investigator ) . Volunteers whose clinical laboratory test value outside accept reference range confirm reexamination deem clinically significant . Volunteers demonstrate positive hepatitis B surface antigen screen , hepatitis C antibody screen reactive HIV antibody screen . Volunteers demonstrate positive drug abuse screen screen study . Female volunteer demonstrate positive pregnancy screen . Female volunteer currently breastfeed . Volunteers history allergic response ( ) benazepril hydrochloride related drug . Volunteers history clinically significant allergy include drug allergy . Volunteers clinically significant illness 4 week prior Period I dose ( determine medical investigator ) . Volunteers currently use tobacco product . Three month abstinence require . Volunteers take drug know induce inhibit hepatic drug metabolism 30 day prior Period I dose . Volunteers report donate great 150 mL blood within 30 day prior Period I dose . All subject advise donate blood four week complete study . Volunteers donate plasma ( e.g . plasmapheresis ) within 14 day prior Period I dose . All subject advise donate plasma four weks complete study . Volunteers report receive investigational drug within 30 day prior period I dose . Volunteers report take prescription medication 14 day prior Period I dose OTC medication within 7 day prior Period I dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>